Filed in archive
Diagnostics
, Treatment
by Gloria Gamat on November 21, 2006

In the past, achieving the correct dose of warfarin is a matter of trial and error that leaves patients vulnerable to the side effects.
This would not be a problem anymore as a FDA blue-ribbon advisory committee is now recommending genotyping patients first before the start of warfarin therapy in order to help reduce potentially fatal and serious adverse reactions to the drug.
The new DNA tests offered by Genelex Corporation will allow Physicians to more accurately determine the correct warfarin dose.
According to Genelex CEO Howard Coleman:
"This is a perfect example of the new movement towards personalized medicine, based on the individuals DNA, rather than prescription by trial and error. The age of "one dose fits all" is ending."
Find more details from the press release (a pdf file). Click here for more info on warfarin DNA test.
Permalink: USFDA Committee Recommends Simple DNA Tests To Patients Prior to Coumadin (Warfarin) Prescription
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/43275
Mr Wong
Vote for USFDA Committee Recommends Simple DNA Tests To Patients Prior to Coumadin (Warfarin) Prescription:
|
Rating: 9.25 out of 4 vote(s) cast.
|
Response from:
Gloria
(11/21/06 6:10pm)
thanks Lisa for the heads up! i'll look into those, as those deserve new entry (ies)
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









